Back to Search
Start Over
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor.
- Source :
-
British Journal of Haematology . Jun2019, Vol. 185 Issue 5, p961-966. 6p. 1 Chart, 1 Graph. - Publication Year :
- 2019
-
Abstract
- The article focuses on a study about administering venetoclax therapy for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor, which have changed the treatment paradigm for chronic lymphocytic leukaemia. Information about the oral BCL2 inhibitor venetoclax is presented.
- Subjects :
- *THROMBOPOIETIN receptors
*T cell receptors
*CHRONIC lymphocytic leukemia
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 185
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 136661957
- Full Text :
- https://doi.org/10.1111/bjh.15666